(1R,2S,5S,6R,7S,10R,11R,14S,16S)-5-[(1R)-1-[(2R,5S)-5-[2-(dimethylamino)pentyl]oxolan-2-yl]ethyl]-2,6,11-trimethyl-14-propyl-4,13,19,20-tetraoxatricyclo[14.2.1.17,10]icosane-3,12-dione
-
(1R,2S,5S,6R,7S,10R,11R,14S,16S)-5-[(1R)-1-[(2R,5S)-5-[2-(dimethylamino)pentyl]oxolan-2-yl]ethyl]-2,6,11-trimethyl-14-propyl-4,13,19,20-tetraoxatricyclo[14.2.1.17,10]icosane-3,12-dione
structure -
-
CAS No:
100905-89-3
-
Formula:
C35H61NO7
-
Chemical Name:
(1R,2S,5S,6R,7S,10R,11R,14S,16S)-5-[(1R)-1-[(2R,5S)-5-[2-(dimethylamino)pentyl]oxolan-2-yl]ethyl]-2,6,11-trimethyl-14-propyl-4,13,19,20-tetraoxatricyclo[14.2.1.17,10]icosane-3,12-dione
-
Synonyms:
panamycin 607;panamycin-607;Panamycin 607;100905-89-3;Panamycin-607;DTXSID50905834;(1R,2S,5S,6R,7S,10R,11R,14S,16S)-5-[(1R)-1-[(2R,5S)-5-[2-(dimethylamino)pentyl]oxolan-2-yl]ethyl]-2,6,11-trimethyl-14-propyl-4,13,19,20-tetraoxatricyclo[14.2.1.17,10]icosane-3,12-dione;4,13,19,20-Tetraoxotricyclo(14.2.1.1(sup 7,10))eicosane-3,12-dione, 5-(1-(5-(2-(dimethylamino)pentyl)tetrahydro-2-furanyl)ethyl)-2,6,11-trimethyl-14-propyl-, (1R-(1R*,2S*,5S*(R*(2R*,5S*(R*))),6R*,7S*,10R*,11R*,14S*,16S*))-;5-(1-{5-[2-(Dimethylamino)pentyl]oxolan-2-yl}ethyl)-2,6,11-trimethyl-14-propyl-4,13,19,20-tetraoxatricyclo[14.2.1.1~7,10~]icosane-3,12-dione
-
CAS No:
(1R,2S,5S,6R,7S,10R,11R,14S,16S)-5-[(1R)-1-[(2R,5S)-5-[2-(dimethylamino)pentyl]oxolan-2-yl]ethyl]-2,6,11-trimethyl-14-propyl-4,13,19,20-tetraoxatricyclo[14.2.1.17,10]icosane-3,12-dione Basic Attributes
607.9 g/mol
607.44480328 g/mol
Computed Properties
Molecular Weight:607.9
XLogP3:7.2
Hydrogen Bond Acceptor Count:8
Rotatable Bond Count:9
Exact Mass:607.44480328
Monoisotopic Mass:607.44480328
Topological Polar Surface Area:83.5
Heavy Atom Count:43
Complexity:897
Defined Atom Stereocenter Count:12
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Request for Quotation